Join us at the MVA Annual Summit 2024 for a day focused on exploring the exciting trends in Medicon Valley and beyond.
Under the theme “Faster, Higher, Stronger Together,” this event will bring together industry leaders, researchers, and experts to delve into the latest advancements and opportunities in the vibrant Medicon Valley region. Don’t miss out on this opportunity to be part of the conversations shaping the future of Medicon Valley.
Date: Monday, November 11th, 2024
Time: 9:30 – 18:00
Venue: Clarion Hotel Copenhagen Airport, Ellehammersvej 20, 2770 Kastrup, Denmark
Participation
Members of MVA and members of the press: Participation is free of charge for members of MVA and members of the press.
Registration ends on November 7th, 2024.
Non-members: Non-members can join the Annual Summit 2024 for a participation fee of 3,995 DKK + VAT. Please note that purchase of this ticket is non-refundable. You can however transfer it to another person at your company if you are prevented from attending the event.
If your company applies for membership within 14 days after the event the cost of that ticket will be deducted from your first membership fee. If you are considering becoming a member of Medicon Valley Alliance, you can find more information here or contact David Munis Zepernick, Director of Member Engagement and Communication (dz@mva.org or +45 2498 1668).
Program
| 9:30 | Registration and coffee |
| 10:00 | Welcome Niels Abel Bonde, Chair of the Board, Medicon Valley Alliance / Corporate Vice President, Novo Nordisk |
| 10:05 | State of Medicon Valley Anette Steenberg, CEO, Medicon Valley Alliance |
|
|
 |
|
|
CMO & CDMO’s in the Medicon Valley ecosystem – a stronghold overlooked |
| 10:25 | How are we positioned and what are the elements needed to further strenthen and develop Medicon Valley as a European Contract Manufacturing hub?
In the panel: |
| 11:15 | Coffee Break
|
|
|
 |
AMR – challenges and initiatives with Antimicrobial Resistance |
|
| 11:45 | What is the nature of the AMR challenge facing global health and how can Sweden and Denmark and current initiatives make a difference for global health?
AMR containment in Sweden and beyond Partnering against AMR – ensuring awareness and policy action Silent invaders: Will pandrug-resistant Gram-negative bacteria in Ukraine break free from hospitals? Discovery and development of novel CRISPR-based precision antibiotics. Emergent global health threats vs. funding gaps |
| 13:00 | Lunch
|
|
|
 |
|
|
Innovative HospitalsHow can technological, scientific and social innovations optimize the performance of existing Danish and Swedish hospitals and healthcare facilities and enhance the diagnostic and therapeutic capabilities? How can they be introduced and how can they change the organization’s culture and give it the agility it needs to transform itself of doctors and professionals? |
| 14:00 | Keynote: The role of innovation in transforming healthcare Fabrice Brunet, MD, President and CEO of QIS, The Health Innovation District of Montreal. Former director general of Centre hospitalier de l’Université de Montréal (CHUM). |
| 14.45 | Panel session
In the panel: |
| 15:20 | Coffee Break
|
|
|
 |
RUBIC – The Golden Egg in Women’s and Men’s Fertility Research |
|
| 15:45 | Speakers: Aleksander Giwercman, Professor, Lund University, Executive Board Member of ReproUnion Henriette Svarre Nielsen, Professor Consultant at University of Copenhagen and Hvidovre Hospital, Founder and Chair Maternity Foundation, Executive Board Member of ReproUnion |
Presentation of the new Swedish Life Science Strategy |
|
| 16:15 | Jeanette Edblad, Director of the Office for Life Sciences, Regeringskansliet |
Closing |
|
| 16:30 | Niels Abel Bonde, Chair of the Board, Medicon Valley Alliance / Corporate Vice President, Novo Nordisk |
| 16.40 | Networking, Snacks & Drinks |
| 18:00 | End of Annual Summit |
Moderator
 |
||
| Lisa Kirsebom Life science journalist & writer |
Keynote Speaker
 |
Dr. Fabrice Brunet is President and CEO of the Montreal Health Innovation District (QIS) and Vice-President at the University of Quebec at Montreal (UQAM), overseeing the creation of its Health Sciences Program. With over 30 years of experience in healthcare, teaching, and research, he has held leadership roles at major institutions, including the academic health centers of Montreal CHUM and Sainte-Justine. He has a strong focus on hospital management, health systems integration, and artificial intelligence in healthcare. Dr. Brunet has published extensively and was named Knight of the Legion of Honor by France in 2018 for his contributions to healthcare. | |
| Fabrice Brunet MD, President and CEO of QIS, The Health Innovation District of Montreal |
Speakers
 |
 |
|
| Niels Abel Bonde Chair of the Board, Medicon Valley Alliance Corporate Vice President, Novo Nordisk |
Anette Steenberg CEO, Medicon Valley Alliance |
|
 |
 |
 |
| Christian Houborg Senior Vice President, Site Denmark, FUJIFILM Diosynth Biotechnologies |
Lena Berdén Site Director, Malmö Polypeptide |
Kenneth Stokholm President & CEO Sever Pharma Solutions |
 |
 |
 |
| Andrea Porchia General Manager AGC Biologics |
Dr. Malin Grape Sweden’s Ambassador on AMR |
Anne Bloch Thomsen MD, PhD, FIND Medical Cluster Lead Pfizer |
 |
 |
 |
| Steffen Pierini Lüders Senior Vice President for Corporate Affairs Novo Nordisk Fonden |
Kristian Riesbeck Professor, Lund University |
Christian Grøndahl CEO and co-founder Snipr-Biome |
 |
 |
 |
| Stefan Jovinge President of Research and Education at Scania University Hospitals |
Rune Holdt Director of Research and Innovation Rigshospitalet |
Anna Mannfalk Regionråd Region Skåne |
 |
 |
 |
| Lars Gaardhøj Chairman of the Regional Council The Capital Region of Denmark |
Aleksander Giwercman Professor, Lund University Executive Board Member of ReproUnion |
Henriette Svarre Nielsen Professor Consultant at University of Copenhagen and Hvidovre Hospital, Founder and Chair Maternity Foundation, Executive Board Member of ReproUnion |
 |
||
| Jeanette Edblad Director of the Office for Life Sciences Regeringskansliet |
Sponsors
 |
 |
 |
 |
 |
Cancellation policy and No-Show-Fee
Cancellations can be made free of charge when they occur before the event takes place and must be sent as soon as possible by email to event@mva.org
If you are unable to attend you are welcome to transfer your registration to a colleague. Please let us know who to transfer the registration to at event@mva.org
In case of non-appearance from the event without cancellation, MVA charge a fee of DKK 500 ex. VAT. The fee covers our incurred costs for catering, room hire and administration.